Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Bank of America downgraded 3D Systems (NYSE: DDD) from “buy” to “underperform.” The price target for 3D Systems has been lowered from $90 to $65. 3D Systems' shares closed at $80.74 on Friday.

Wells Fargo downgraded Halliburton Company (NYSE: HAL) from “outperform” to “market perform.” Halliburton's shares closed at $55.30 on Friday.

Analysts at Imperial Capital downgraded Builders FirstSource (NASDAQ: BLDR) from “outperform” to “in-line.” The target price for Builders FirstSource has been raised from $8.50 to $9.50. Builders FirstSource's shares closed at $8.74 on Friday.

Analysts at Standpoint Research downgraded Apple (NASDAQ: AAPL) from “sell” to “strong sell.” Apple's shares closed at $525.25 on Friday.

Latest Ratings for DDD

DateFirmActionFromTo
Aug 2019DowngradesNeutralUnderweight
Jun 2019UpgradesSellNeutral
May 2019UpgradesUnderweightNeutral

View More Analyst Ratings for DDD
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AAPL + BLDR)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
SRPTPiperJaffrayMaintains210.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

FLY Leasing Acquires Two Boeing 737s

UPDATE: H.C. Wainwright & Co. Initiates Coverage on Agenus Following 4-Antibody Acquisition